|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2003-12-11
|
|
pubmed:abstractText |
New therapies are needed to improve the prognosis of patients with advanced hepatocellular carcinoma (HCC). Various gemcitabine-oxaliplatin combinations have been tested recently in patients with ovarian and pancreatic carcinoma, yielding interesting results with little toxicity. Therefore, the authors evaluated the activity and toxicity of two such combinations in patients with HCC.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
pubmed-author:BoigeValerieV,
pubmed-author:BoleslawskiEmmanuelE,
pubmed-author:BonyhayLuminitaL,
pubmed-author:DelgadoMarie AnnaMA,
pubmed-author:DucreuxMichelM,
pubmed-author:GolliLamiaL,
pubmed-author:HannounLaureutL,
pubmed-author:MansourbakhtTourajT,
pubmed-author:PoynardThierryT,
pubmed-author:TaïebJulienJ,
pubmed-author:TigaudJean-MarieJM,
pubmed-author:de BaereThierryT
|
|
pubmed:copyrightInfo |
Copyright 2003 American Cancer Society.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
98
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2664-70
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:14669287-Adult,
pubmed-meshheading:14669287-Aged,
pubmed-meshheading:14669287-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:14669287-Carcinoma, Hepatocellular,
pubmed-meshheading:14669287-Deoxycytidine,
pubmed-meshheading:14669287-Disease-Free Survival,
pubmed-meshheading:14669287-Dose-Response Relationship, Drug,
pubmed-meshheading:14669287-Drug Administration Schedule,
pubmed-meshheading:14669287-Female,
pubmed-meshheading:14669287-Humans,
pubmed-meshheading:14669287-Liver Neoplasms,
pubmed-meshheading:14669287-Male,
pubmed-meshheading:14669287-Middle Aged,
pubmed-meshheading:14669287-Organoplatinum Compounds,
pubmed-meshheading:14669287-Prospective Studies,
pubmed-meshheading:14669287-Survival Rate,
pubmed-meshheading:14669287-Treatment Outcome
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Gemcitabine plus oxaliplatin for patients with advanced hepatocellular carcinoma using two different schedules.
|
|
pubmed:affiliation |
Service d'Hépato-gastro-entérologie, Groupe Hospitalier Pitié Salpétrière, Paris, France. jtaieb@club-internet.fr
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
